| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | WW domain binding | 1.24e-04 | 25 | 78 | 3 | GO:0050699 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.12e-05 | 36 | 80 | 4 | GO:0035459 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.51e-07 | 42 | 80 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | nuclear body | WBP11 RBM25 SETD1B NFATC4 RBBP6 CPSF6 YLPM1 DVL2 RERE MAPK7 SKI SF3A2 | 1.58e-04 | 903 | 80 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | 2.43e-04 | 431 | 80 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 MLXIPL RBM22 SETD1B CPSF6 BICRA MED25 RERE KDM6B PDCD7 POLR1G MIDEAS UVRAG SF3A2 | 6.77e-04 | 1377 | 80 | 14 | GO:0140513 |
| HumanPheno | High hypermetropia | 5.84e-05 | 82 | 27 | 5 | HP:0008499 | |
| HumanPheno | Self-injurious behavior | 8.04e-05 | 210 | 27 | 7 | HP:0100716 | |
| HumanPheno | Hypermetropia | 8.18e-05 | 288 | 27 | 8 | HP:0000540 | |
| HumanPheno | Disinhibition | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 8.25e-05 | 807 | 27 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 8.25e-05 | 807 | 27 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 8.25e-05 | 807 | 27 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 8.25e-05 | 807 | 27 | 13 | HP:5200029 |
| HumanPheno | Impairment in personality functioning | MLXIPL TREX1 WBP11 MAGEL2 AGO2 SETD1B ANXA11 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 1.80e-04 | 1141 | 27 | 15 | HP:0031466 |
| HumanPheno | Abnormally increased volition | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 1.81e-04 | 869 | 27 | 13 | HP:5200263 |
| HumanPheno | Recurrent maladaptive behavior | MLXIPL TREX1 WBP11 MAGEL2 AGO2 SETD1B BICRA ANXA11 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 1.88e-04 | 1293 | 27 | 16 | HP:5200241 |
| HumanPheno | Strabismus | MLXIPL TREX1 MAGEL2 FBN1 AGO2 SOBP BICRA MED25 RERE KDM6B SKI WASF1 RAX RAI1 SCAF4 | 2.17e-04 | 1159 | 27 | 15 | HP:0000486 |
| HumanPheno | Language impairment | TREX1 MAGEL2 AGO2 SETD1B SOBP ANXA11 MED25 FMN2 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 2.63e-04 | 1178 | 27 | 15 | HP:0002463 |
| HumanPheno | Abnormal social development | MLXIPL TREX1 WBP11 MAGEL2 AGO2 MED25 TOMM40 RERE KDM6B SKI WASF1 RAI1 SCAF4 | 2.86e-04 | 908 | 27 | 13 | HP:0025732 |
| HumanPheno | Abnormal conjugate eye movement | MLXIPL TREX1 MAGEL2 FBN1 AGO2 SOBP BICRA MED25 RERE KDM6B SKI WASF1 RAX RAI1 SCAF4 | 3.21e-04 | 1198 | 27 | 15 | HP:0000549 |
| HumanPheno | Bicuspid aortic valve | 3.42e-04 | 119 | 27 | 5 | HP:0001647 | |
| HumanPheno | Deeply set eye | 3.52e-04 | 266 | 27 | 7 | HP:0000490 | |
| HumanPheno | Chronic constipation | 3.56e-04 | 120 | 27 | 5 | HP:0012450 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 3.70e-04 | 121 | 27 | 5 | HP:0031567 | |
| MousePheno | decreased skeletal muscle fiber size | 5.86e-05 | 97 | 60 | 5 | MP:0009400 | |
| MousePheno | embryonic lethality prior to organogenesis | DCAF1 RBM22 WBP11 RBM25 FBN1 AGO2 WTIP RBBP6 CTAGE8 YLPM1 TOMM40 PDCD7 POLR1G RAI1 DNM2 | 1.27e-04 | 1204 | 60 | 15 | MP:0013292 |
| MousePheno | abnormal craniofacial morphology | TREX1 WBP11 MIA3 FBN1 DMRT3 RASA1 FAM120C GLG1 RERE MAPK7 SKI FOXI3 RAX SOCS7 RAI1 DNM2 | 1.56e-04 | 1372 | 60 | 16 | MP:0000428 |
| MousePheno | craniofacial phenotype | TREX1 WBP11 MIA3 FBN1 DMRT3 RASA1 FAM120C GLG1 RERE MAPK7 SKI FOXI3 RAX SOCS7 RAI1 DNM2 | 1.56e-04 | 1372 | 60 | 16 | MP:0005382 |
| MousePheno | embryonic lethality prior to tooth bud stage | DCAF1 RBM22 WBP11 RBM25 FBN1 AGO2 RASA1 WTIP RBBP6 CTAGE8 YLPM1 TOMM40 PDCD7 POLR1G RAI1 DNM2 | 1.71e-04 | 1383 | 60 | 16 | MP:0013293 |
| MousePheno | abnormal food intake | 1.95e-04 | 481 | 60 | 9 | MP:0005449 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 2.04e-04 | 27 | 60 | 3 | MP:0008438 | |
| MousePheno | decreased skeletal muscle mass | 2.42e-04 | 131 | 60 | 5 | MP:0004819 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 2.87e-04 | 212 | 60 | 6 | MP:0003084 | |
| MousePheno | decreased food intake | 2.98e-04 | 137 | 60 | 5 | MP:0011940 | |
| MousePheno | abnormal muscle fiber morphology | 3.22e-04 | 406 | 60 | 8 | MP:0004087 | |
| MousePheno | abnormal skeletal muscle fiber size | 3.29e-04 | 140 | 60 | 5 | MP:0009398 | |
| MousePheno | abnormal fetal growth/weight/body size | 3.61e-04 | 312 | 60 | 7 | MP:0004197 | |
| MousePheno | abnormal presacral vertebrae morphology | 3.94e-04 | 225 | 60 | 6 | MP:0000459 | |
| MousePheno | abnormal spine curvature | 4.05e-04 | 318 | 60 | 7 | MP:0004174 | |
| MousePheno | decreased fetal size | 4.33e-04 | 229 | 60 | 6 | MP:0004200 | |
| MousePheno | abnormal skeletal muscle mass | 4.38e-04 | 149 | 60 | 5 | MP:0004817 | |
| MousePheno | double outlet right ventricle | 4.52e-04 | 150 | 60 | 5 | MP:0000284 | |
| Domain | SMR-like | 4.76e-05 | 3 | 75 | 2 | IPR026288 | |
| Domain | PROL5-SMR | 4.76e-05 | 3 | 75 | 2 | PF15621 | |
| Domain | SANT_dom | 1.51e-04 | 26 | 75 | 3 | IPR017884 | |
| Domain | - | 1.58e-04 | 5 | 75 | 2 | 1.20.1390.10 | |
| Domain | PWI | 1.58e-04 | 5 | 75 | 2 | PF01480 | |
| Domain | PWI_dom | 1.58e-04 | 5 | 75 | 2 | IPR002483 | |
| Domain | RRM_1 | 1.89e-04 | 208 | 75 | 6 | PF00076 | |
| Domain | SANT | 1.90e-04 | 28 | 75 | 3 | PS51293 | |
| Domain | RRM | 2.37e-04 | 217 | 75 | 6 | SM00360 | |
| Domain | RRM_dom | 3.02e-04 | 227 | 75 | 6 | IPR000504 | |
| Domain | RRM | 3.24e-04 | 230 | 75 | 6 | PS50102 | |
| Domain | Myb_DNA-binding | 3.71e-04 | 35 | 75 | 3 | PF00249 | |
| Domain | - | 4.44e-04 | 244 | 75 | 6 | 3.30.70.330 | |
| Domain | MYB_LIKE | 4.74e-04 | 38 | 75 | 3 | PS50090 | |
| Domain | Nucleotide-bd_a/b_plait | 5.95e-04 | 258 | 75 | 6 | IPR012677 | |
| Domain | TF_fork_head_CS_2 | 8.34e-04 | 46 | 75 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 8.88e-04 | 47 | 75 | 3 | IPR018122 | |
| Domain | ZnF_C3H1 | 9.45e-04 | 48 | 75 | 3 | SM00356 | |
| Domain | zf-CCCH | 1.00e-03 | 49 | 75 | 3 | PF00642 | |
| Domain | FH | 1.00e-03 | 49 | 75 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.00e-03 | 49 | 75 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.00e-03 | 49 | 75 | 3 | PS00658 | |
| Domain | Fork_head_dom | 1.00e-03 | 49 | 75 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.00e-03 | 49 | 75 | 3 | PS50039 | |
| Domain | Forkhead | 1.00e-03 | 49 | 75 | 3 | PF00250 | |
| Domain | SANT | 1.06e-03 | 50 | 75 | 3 | SM00717 | |
| Domain | SANT/Myb | 1.19e-03 | 52 | 75 | 3 | IPR001005 | |
| Domain | ELM2 | 1.21e-03 | 13 | 75 | 2 | PF01448 | |
| Domain | ELM2 | 1.21e-03 | 13 | 75 | 2 | PS51156 | |
| Domain | ELM2_dom | 1.21e-03 | 13 | 75 | 2 | IPR000949 | |
| Domain | ELM2 | 1.21e-03 | 13 | 75 | 2 | SM01189 | |
| Domain | WH2 | 1.40e-03 | 14 | 75 | 2 | SM00246 | |
| Domain | Znf_CCCH | 1.64e-03 | 58 | 75 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 1.64e-03 | 58 | 75 | 3 | PS50103 | |
| Domain | WH2 | 1.84e-03 | 16 | 75 | 2 | PF02205 | |
| Domain | WH2_dom | 3.18e-03 | 21 | 75 | 2 | IPR003124 | |
| Domain | DEP_dom | 3.81e-03 | 23 | 75 | 2 | IPR000591 | |
| Domain | WH2 | 4.15e-03 | 24 | 75 | 2 | PS51082 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | PRR12 SOBP BICRA FBRS SEC16A TPRX1 TPRX2 RERE SKI MIDEAS RAI1 | 5.33e-10 | 351 | 80 | 11 | 38297188 |
| Pubmed | WBP11 RBM25 RBBP6 CPSF6 BICRA YLPM1 RBM26 SEC16A DVL2 PRRC2A SF3A2 | 2.04e-09 | 399 | 80 | 11 | 35987950 | |
| Pubmed | 2.16e-09 | 220 | 80 | 9 | 24550385 | ||
| Pubmed | 1.21e-08 | 268 | 80 | 9 | 33640491 | ||
| Pubmed | PRR12 WBP11 RBM25 FBN1 AGO2 NFATC4 RBBP6 SOBP BICRA YLPM1 FBRS SEC16A RERE SKI MIDEAS PRRC2A SCAF4 | 2.15e-08 | 1429 | 80 | 17 | 35140242 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RBM22 WBP11 RBM25 AGO2 RBBP6 FAM120C CPSF6 ANXA11 YLPM1 RBM26 PRRC2A SF3A2 SCAF4 | 3.87e-08 | 807 | 80 | 13 | 22681889 |
| Pubmed | DCAF1 RBM25 AGO2 RBBP6 FAM120C BICRA FBRS SEC16A DVL2 FMN2 RERE SKI POLR1G RAI1 | 2.37e-07 | 1116 | 80 | 14 | 31753913 | |
| Pubmed | PRR12 RBM22 RBBP6 FAM120C CPSF6 GLG1 RBM26 MED25 TOMM40 DNAJC1 PDCD7 POLR1G PRRC2A SF3A2 SCAF4 SEMA4C | 2.55e-07 | 1497 | 80 | 16 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WBP11 RBM25 RBBP6 CPSF6 BICRA ANXA11 YLPM1 RBM26 SEC16A MIDEAS PRRC2A RAI1 SCAF4 | 2.65e-07 | 954 | 80 | 13 | 36373674 |
| Pubmed | WBP11 MIA3 AGO2 WTIP FAM120C YLPM1 SEC16A DVL2 HCN2 WASF1 PRRC2A RAI1 DNM2 | 2.95e-07 | 963 | 80 | 13 | 28671696 | |
| Pubmed | 1.02e-06 | 143 | 80 | 6 | 32560809 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.10e-06 | 457 | 80 | 9 | 32344865 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXN1 MLXIPL TSC22D1 DMRT3 NFATC4 FOXD4L3 TPRX1 RERE SKI FOXI3 MIDEAS RAX | 1.10e-06 | 908 | 80 | 12 | 19274049 |
| Pubmed | GPALPP1 PRR12 RBM22 WBP11 CPSF6 BICRA RBM26 MIDEAS PRRC2A SF3A2 RAI1 DNM2 SCAF4 | 1.35e-06 | 1103 | 80 | 13 | 34189442 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRR12 MLXIPL TREX1 RBM22 RBM25 RBBP6 YLPM1 DNAJC1 SKI POLR1G MIDEAS SF3A2 RAI1 SCAF4 | 1.38e-06 | 1294 | 80 | 14 | 30804502 |
| Pubmed | 1.45e-06 | 152 | 80 | 6 | 38360978 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.57e-06 | 154 | 80 | 6 | 16055720 | |
| Pubmed | 2.53e-06 | 506 | 80 | 9 | 30890647 | ||
| Pubmed | 4.89e-06 | 549 | 80 | 9 | 38280479 | ||
| Pubmed | A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | 5.23e-06 | 2 | 80 | 2 | 28123933 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 27878831 | ||
| Pubmed | 6.42e-06 | 16 | 80 | 3 | 32414810 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.41e-05 | 341 | 80 | 7 | 32971831 | |
| Pubmed | WBP11 RBM25 AGO2 FAM120C CPSF6 YLPM1 RBM26 SEC16A PDCD7 MIDEAS MUC5AC PRRC2A SCAF4 | 1.42e-05 | 1371 | 80 | 13 | 36244648 | |
| Pubmed | HRD1-ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination. | 1.57e-05 | 3 | 80 | 2 | 30389664 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 36074823 | ||
| Pubmed | miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. | 1.57e-05 | 3 | 80 | 2 | 19855844 | |
| Pubmed | FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver. | 1.57e-05 | 3 | 80 | 2 | 26724858 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 32042044 | ||
| Pubmed | FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway. | 1.57e-05 | 3 | 80 | 2 | 24848261 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 24583134 | ||
| Pubmed | 1.94e-05 | 653 | 80 | 9 | 33742100 | ||
| Pubmed | 1.99e-05 | 655 | 80 | 9 | 35819319 | ||
| Pubmed | 2.56e-05 | 251 | 80 | 6 | 31076518 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 18347059 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 27412763 | ||
| Pubmed | The role of Dicer protein partners in the processing of microRNA precursors. | 3.13e-05 | 4 | 80 | 2 | 22163034 | |
| Pubmed | Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN. | 3.13e-05 | 4 | 80 | 2 | 38408184 | |
| Pubmed | GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population. | 3.13e-05 | 4 | 80 | 2 | 30128886 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | RBM22 WBP11 RBBP6 CPSF6 GLG1 YLPM1 SEC16A WASF1 PRRC2A SCAF4 | 5.03e-05 | 922 | 80 | 10 | 27609421 |
| Pubmed | 5.03e-05 | 31 | 80 | 3 | 19041431 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 5.20e-05 | 5 | 80 | 2 | 15183315 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPALPP1 RBBP6 CPSF6 YLPM1 RBM26 SEC16A DVL2 PRRC2A DNM2 SCAF4 | 5.60e-05 | 934 | 80 | 10 | 33916271 |
| Pubmed | 5.71e-05 | 425 | 80 | 7 | 24999758 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.17e-05 | 180 | 80 | 5 | 35198878 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 6.50e-05 | 182 | 80 | 5 | 32239614 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.84e-05 | 184 | 80 | 5 | 32908313 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.24e-05 | 774 | 80 | 9 | 15302935 | |
| Pubmed | TANGO1 recruits Sec16 to coordinately organize ER exit sites for efficient secretion. | 7.79e-05 | 6 | 80 | 2 | 28442536 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 19955471 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 21880741 | ||
| Pubmed | PSMC3 promotes RNAi by maintaining AGO2 stability through USP14. | 7.79e-05 | 6 | 80 | 2 | 36528617 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 RBM22 WBP11 RBM25 CPSF6 YLPM1 RBM26 POLR1G MIDEAS SF3A2 | 8.99e-05 | 989 | 80 | 10 | 36424410 |
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 28683311 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.14e-04 | 475 | 80 | 7 | 31040226 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | GPALPP1 MLXIPL SHROOM1 CPSF6 RBM26 FBRS SEC16A DVL2 MAPK7 UVRAG | 1.33e-04 | 1038 | 80 | 10 | 26673895 |
| Pubmed | Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy. | 1.45e-04 | 8 | 80 | 2 | 19336575 | |
| Pubmed | RBBP6 activates the pre-mRNA 3' end processing machinery in humans. | 1.45e-04 | 8 | 80 | 2 | 35177536 | |
| Pubmed | Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. | 1.45e-04 | 8 | 80 | 2 | 22542159 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SBK1 COL23A1 TSC22D1 MIA3 AGO2 RASA1 FAM120C SOBP BICRA RERE SKI RAI1 | 1.48e-04 | 1489 | 80 | 12 | 28611215 |
| Pubmed | 1.53e-04 | 347 | 80 | 6 | 16033648 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.56e-04 | 857 | 80 | 9 | 25609649 | |
| Pubmed | 1.62e-04 | 503 | 80 | 7 | 16964243 | ||
| Pubmed | 1.63e-04 | 118 | 80 | 4 | 21078624 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.69e-04 | 678 | 80 | 8 | 30209976 | |
| Pubmed | RBM22 WBP11 FBN1 YLPM1 NFKBID FMN2 KDM6B PDCD7 PRRC2A SF3A2 DNM2 | 1.70e-04 | 1285 | 80 | 11 | 35914814 | |
| Pubmed | 1.86e-04 | 360 | 80 | 6 | 33111431 | ||
| Pubmed | Formin 2 Regulates Lysosomal Degradation of Wnt-Associated β-Catenin in Neural Progenitors. | 1.86e-04 | 9 | 80 | 2 | 29659741 | |
| Pubmed | LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing. | 1.86e-04 | 9 | 80 | 2 | 20616046 | |
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 1.86e-04 | 9 | 80 | 2 | 33524014 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.87e-04 | 1082 | 80 | 10 | 38697112 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GPALPP1 RBM22 RBM25 RBBP6 CPSF6 SEC16A DVL2 TOMM40 POLR1G SF3A2 DNM2 | 2.12e-04 | 1318 | 80 | 11 | 30463901 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRR12 SETD1B BICRA ANXA11 FBRS SEC16A SYVN1 KDM6B UVRAG RAI1 | 2.21e-04 | 1105 | 80 | 10 | 35748872 |
| Pubmed | 2.32e-04 | 10 | 80 | 2 | 10744724 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.37e-04 | 130 | 80 | 4 | 35545047 | |
| Pubmed | 2.84e-04 | 11 | 80 | 2 | 20598684 | ||
| Pubmed | 2.91e-04 | 251 | 80 | 5 | 28077445 | ||
| Pubmed | Strain-specific modifier genes governing craniofacial phenotypes. | 3.40e-04 | 12 | 80 | 2 | 22371338 | |
| Pubmed | Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. | 3.40e-04 | 12 | 80 | 2 | 7596406 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.78e-04 | 147 | 80 | 4 | 28977470 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.87e-04 | 148 | 80 | 4 | 32538781 | |
| Pubmed | 3.87e-04 | 148 | 80 | 4 | 35676246 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 4.01e-04 | 13 | 80 | 2 | 11839810 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.33e-04 | 1203 | 80 | 10 | 29180619 | |
| Pubmed | 4.39e-04 | 153 | 80 | 4 | 28225217 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.79e-04 | 430 | 80 | 6 | 35044719 | |
| Pubmed | 4.87e-04 | 281 | 80 | 5 | 24163370 | ||
| Pubmed | 5.08e-04 | 1007 | 80 | 9 | 34597346 | ||
| Pubmed | 5.22e-04 | 437 | 80 | 6 | 20562859 | ||
| Pubmed | Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. | 5.38e-04 | 15 | 80 | 2 | 16530750 | |
| Pubmed | 5.38e-04 | 15 | 80 | 2 | 23523356 | ||
| Pubmed | BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. | 5.38e-04 | 15 | 80 | 2 | 12931191 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.41e-04 | 440 | 80 | 6 | 34244565 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 5.45e-04 | 162 | 80 | 4 | 31363146 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.53e-04 | 289 | 80 | 5 | 23752268 | |
| Pubmed | 5.72e-04 | 1247 | 80 | 10 | 27684187 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 6.08e-04 | 450 | 80 | 6 | 16751776 | |
| Pubmed | 6.51e-04 | 634 | 80 | 7 | 34591612 | ||
| Pubmed | HIV-1 accessory proteins--ensuring viral survival in a hostile environment. | 6.95e-04 | 17 | 80 | 2 | 18541215 | |
| Pubmed | LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. | 6.95e-04 | 17 | 80 | 2 | 31868085 | |
| Interaction | NCK2 interactions | WBP11 MIA3 CPSF6 YLPM1 RBM26 WIPF3 NFKBID WASF1 PRRC2A SF3A2 SOCS7 | 6.90e-09 | 262 | 80 | 11 | int:NCK2 |
| Interaction | ALG13 interactions | 4.59e-08 | 183 | 80 | 9 | int:ALG13 | |
| Interaction | CTAGE1 interactions | 4.75e-08 | 10 | 80 | 4 | int:CTAGE1 | |
| Interaction | WWOX interactions | RBM22 MIA3 DMRT3 CPSF6 ANXA11 YLPM1 FBRS DVL2 MED25 SMR3A PDCD7 PRRC2A SF3A2 SCAF4 | 1.56e-07 | 627 | 80 | 14 | int:WWOX |
| Interaction | WBP4 interactions | 2.56e-07 | 109 | 80 | 7 | int:WBP4 | |
| Interaction | SP7 interactions | 3.41e-07 | 304 | 80 | 10 | int:SP7 | |
| Interaction | GRB2 interactions | DCAF1 MLXIPL WBP11 RASA1 RBBP6 CPSF6 YLPM1 WIPF3 DVL2 HCN2 WASF1 PRRC2A SF3A2 SOCS7 DNM2 | 5.52e-07 | 806 | 80 | 15 | int:GRB2 |
| Interaction | PRMT2 interactions | 1.65e-06 | 91 | 80 | 6 | int:PRMT2 | |
| Interaction | KLHL12 interactions | 3.60e-06 | 104 | 80 | 6 | int:KLHL12 | |
| Interaction | TRIP10 interactions | 4.73e-06 | 109 | 80 | 6 | int:TRIP10 | |
| Interaction | KRTAP6-2 interactions | 9.50e-06 | 187 | 80 | 7 | int:KRTAP6-2 | |
| Interaction | MAPKAPK2 interactions | 1.55e-05 | 134 | 80 | 6 | int:MAPKAPK2 | |
| Interaction | GSC interactions | 2.49e-05 | 87 | 80 | 5 | int:GSC | |
| Interaction | MIA3 interactions | 3.71e-05 | 231 | 80 | 7 | int:MIA3 | |
| Interaction | NUP35 interactions | 4.60e-05 | 424 | 80 | 9 | int:NUP35 | |
| Interaction | GAGE5 interactions | 5.39e-05 | 52 | 80 | 4 | int:GAGE5 | |
| Interaction | EGR2 interactions | 6.11e-05 | 171 | 80 | 6 | int:EGR2 | |
| Interaction | SNRPC interactions | 6.11e-05 | 440 | 80 | 9 | int:SNRPC | |
| Interaction | PLSCR1 interactions | 6.31e-05 | 172 | 80 | 6 | int:PLSCR1 | |
| Interaction | CFAP141 interactions | 6.73e-05 | 55 | 80 | 4 | int:CFAP141 | |
| Interaction | CRX interactions | 6.75e-05 | 254 | 80 | 7 | int:CRX | |
| Interaction | ANKRD50 interactions | 7.03e-05 | 108 | 80 | 5 | int:ANKRD50 | |
| Interaction | SH3RF1 interactions | 7.03e-05 | 108 | 80 | 5 | int:SH3RF1 | |
| Interaction | ATN1 interactions | 1.00e-04 | 187 | 80 | 6 | int:ATN1 | |
| Interaction | TLE3 interactions | 1.23e-04 | 376 | 80 | 8 | int:TLE3 | |
| Interaction | SNRPF interactions | 1.44e-04 | 385 | 80 | 8 | int:SNRPF | |
| Interaction | SMC5 interactions | WBP11 RBM25 RBBP6 CPSF6 BICRA ANXA11 YLPM1 RBM26 SEC16A MIDEAS PRRC2A RAI1 SCAF4 | 1.46e-04 | 1000 | 80 | 13 | int:SMC5 |
| Interaction | CELF1 interactions | 1.48e-04 | 288 | 80 | 7 | int:CELF1 | |
| Interaction | CTAGE15 interactions | 1.54e-04 | 5 | 80 | 2 | int:CTAGE15 | |
| Interaction | DHX8 interactions | 1.61e-04 | 292 | 80 | 7 | int:DHX8 | |
| Interaction | MEN1 interactions | PRR12 RBM25 SETD1B RBBP6 FAM120C CPSF6 YLPM1 RBM26 RERE POLR1G MIDEAS PRRC2A SF3A2 | 1.94e-04 | 1029 | 80 | 13 | int:MEN1 |
| Interaction | TNRC6C interactions | 2.23e-04 | 138 | 80 | 5 | int:TNRC6C | |
| Interaction | CTAGE7P interactions | 2.31e-04 | 6 | 80 | 2 | int:CTAGE7P | |
| Interaction | CTAGE6 interactions | 2.31e-04 | 6 | 80 | 2 | int:CTAGE6 | |
| Interaction | CTAGE8 interactions | 2.31e-04 | 6 | 80 | 2 | int:CTAGE8 | |
| Interaction | CPSF6 interactions | 2.35e-04 | 526 | 80 | 9 | int:CPSF6 | |
| Interaction | DDX20 interactions | 2.67e-04 | 224 | 80 | 6 | int:DDX20 | |
| Interaction | SMG7 interactions | 2.76e-04 | 319 | 80 | 7 | int:SMG7 | |
| Interaction | RNPS1 interactions | 2.82e-04 | 425 | 80 | 8 | int:RNPS1 | |
| Interaction | ITSN2 interactions | 2.99e-04 | 147 | 80 | 5 | int:ITSN2 | |
| Interaction | PSENEN interactions | 3.04e-04 | 81 | 80 | 4 | int:PSENEN | |
| Interaction | FXR1 interactions | 3.47e-04 | 679 | 80 | 10 | int:FXR1 | |
| Interaction | CEBPA interactions | GPALPP1 PRR12 RBM22 WBP11 NFATC4 CPSF6 BICRA RBM26 MIDEAS PRRC2A SF3A2 RAI1 DNM2 SCAF4 | 3.56e-04 | 1245 | 80 | 14 | int:CEBPA |
| Interaction | PRPF40A interactions | 3.89e-04 | 446 | 80 | 8 | int:PRPF40A | |
| Interaction | ACTC1 interactions | 4.12e-04 | 694 | 80 | 10 | int:ACTC1 | |
| Interaction | EYA4 interactions | 4.12e-04 | 243 | 80 | 6 | int:EYA4 | |
| Interaction | OSTF1 interactions | 4.54e-04 | 90 | 80 | 4 | int:OSTF1 | |
| Interaction | NXN interactions | 4.60e-04 | 38 | 80 | 3 | int:NXN | |
| Interaction | FOXI1 interactions | 4.93e-04 | 92 | 80 | 4 | int:FOXI1 | |
| Interaction | PRM2 interactions | 4.97e-04 | 39 | 80 | 3 | int:PRM2 | |
| Interaction | SMARCC2 interactions | 5.06e-04 | 353 | 80 | 7 | int:SMARCC2 | |
| Interaction | AR interactions | PRR12 RBM25 RASA1 CPSF6 YLPM1 RBM26 FBRS SEC16A RERE SKI MIDEAS RAI1 | 5.18e-04 | 992 | 80 | 12 | int:AR |
| Interaction | SNRPB2 interactions | 5.32e-04 | 255 | 80 | 6 | int:SNRPB2 | |
| Interaction | GARRE1 interactions | 5.36e-04 | 167 | 80 | 5 | int:GARRE1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PRR12 WTIP BICRA FGF21 PRR19 MED25 NFKBID TPRX1 TPRX2 TOMM40 POLR1G | 7.04e-06 | 1192 | 80 | 11 | chr19q13 |
| Cytoband | 4q13.3 | 5.57e-05 | 42 | 80 | 3 | 4q13.3 | |
| Cytoband | 7q35 | 1.25e-04 | 55 | 80 | 3 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 2.15e-04 | 66 | 80 | 3 | chr7q35 | |
| Cytoband | 19q13.3 | 4.09e-04 | 82 | 80 | 3 | 19q13.3 | |
| Cytoband | 14q24.3 | 5.91e-04 | 93 | 80 | 3 | 14q24.3 | |
| Cytoband | 19q13.33 | 8.64e-04 | 106 | 80 | 3 | 19q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.66e-03 | 157 | 80 | 3 | chr4q13 | |
| GeneFamily | CTAGE family | 7.81e-06 | 15 | 48 | 3 | 907 | |
| GeneFamily | RNA binding motif containing | 2.02e-05 | 213 | 48 | 6 | 725 | |
| GeneFamily | Zinc fingers CCCH-type | 1.08e-04 | 35 | 48 | 3 | 73 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.75e-04 | 53 | 48 | 3 | 532 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.87e-03 | 92 | 48 | 3 | 521 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 4.48e-06 | 193 | 78 | 7 | 3262_UP | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 2.92e-05 | 104 | 78 | 5 | ctd:C000595015 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.07e-05 | 184 | 78 | 6 | 1064_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 4.73e-05 | 189 | 78 | 6 | 3084_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 5.31e-05 | 193 | 78 | 6 | 6733_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 7169_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; HL60; HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1556_DN | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 3242_UP | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 6563_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1215_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.12e-05 | 198 | 78 | 6 | 4536_DN | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 4543_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 6.47e-05 | 200 | 78 | 6 | 2648_UP | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 6.47e-05 | 200 | 78 | 6 | 7308_DN | |
| Disease | Shprintzen-Goldberg syndrome | 5.71e-06 | 2 | 71 | 2 | C1321551 | |
| Disease | migraine disorder, type 1 diabetes mellitus | 5.68e-05 | 5 | 71 | 2 | MONDO_0005147, MONDO_0005277 | |
| Disease | Chromosome 1p36 Deletion Syndrome | 5.68e-05 | 5 | 71 | 2 | C1842870 | |
| Disease | triglycerides in HDL measurement | 2.87e-04 | 53 | 71 | 3 | EFO_0022317 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 3.71e-04 | 12 | 71 | 2 | OBA_2045171 | |
| Disease | respiratory system disease | 4.21e-04 | 145 | 71 | 4 | EFO_0000684 | |
| Disease | granulocyte percentage of myeloid white cells | 4.75e-04 | 268 | 71 | 5 | EFO_0007997 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.29e-04 | 447 | 71 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.13e-03 | 189 | 71 | 4 | EFO_0009932 | |
| Disease | fat intake measurement | 1.28e-03 | 22 | 71 | 2 | EFO_0010809 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.29e-03 | 335 | 71 | 5 | EFO_0009931 | |
| Disease | body fat percentage, coronary artery disease | 1.52e-03 | 24 | 71 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | serum non-albumin protein measurement | 1.79e-03 | 361 | 71 | 5 | EFO_0004568 | |
| Disease | monocyte percentage of leukocytes | 1.87e-03 | 731 | 71 | 7 | EFO_0007989 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 1.93e-03 | 27 | 71 | 2 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | sodium measurement | 1.99e-03 | 103 | 71 | 3 | EFO_0009282 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQPPVTYPGQPPVPL | 146 | P50995 | |
| PGFIPPPLAPVRGPL | 691 | Q86UF2 | |
| PGFIPPPLAPVRGPL | 691 | P0CG41 | |
| PGFIPPPLAPVRGPL | 691 | A4D2H0 | |
| QLGLVPFPPPPPRTP | 16 | Q96KC8 | |
| PVPPAVQPPGAPPVR | 691 | O14641 | |
| GPALAPPAPPPPIQG | 6 | Q9UKV8 | |
| PPPPQPQPLPAGVAK | 126 | Q7Z5J4 | |
| GPPAVVNIALPPPPG | 356 | Q9NW64 | |
| VNIALPPPPGIAPPP | 361 | Q9NW64 | |
| ALPPGIPPPQFPGFP | 16 | P49756 | |
| FPAQPPVVEGPPPPG | 331 | Q5T8P6 | |
| PLPPPPYLPPLGAGL | 136 | P20936 | |
| PGVLPYFPPGLPPPD | 681 | Q13164 | |
| PQPRPPQGPLALPGP | 931 | Q9Y4B6 | |
| PPPPPGAAAGPFLQP | 81 | A8MTJ6 | |
| QPPALGGPIVPAPPL | 81 | Q9UJ55 | |
| PPSGPPQFPAVVPGP | 11 | Q8NI38 | |
| PRPGPLLGAPAPPQP | 231 | Q6VB84 | |
| EQTGLPPGLPLPPPP | 236 | O15054 | |
| QLIVEPGPPGPPGPP | 406 | Q86Y22 | |
| FFGQGRPGPPPPQPP | 6 | Q8N8D1 | |
| AFPPPLPQRPGPFPG | 36 | Q8N8D1 | |
| PGVNFVPGPLPPPIP | 376 | Q9H1Q7 | |
| PPALPEPPGILAPQP | 171 | Q9NSA1 | |
| SGPPPPGPILRPQNP | 626 | Q71SY5 | |
| PLPPACPLPGFVPVP | 5316 | P98088 | |
| YPPPAPGIPPVNPLA | 81 | Q9NZ81 | |
| PPAVRGPTPGPPLIP | 781 | P50570 | |
| TLPLPPGVPPPQFSP | 571 | Q7Z6E9 | |
| PGVPPPQFSPQFPPG | 576 | Q7Z6E9 | |
| PGLPPQPPPPVAQLV | 156 | Q86Y26 | |
| VPPLPPRGFPFVPPS | 101 | Q6MZM9 | |
| QPPQPPFPAGGPPAR | 86 | Q92896 | |
| FPPAVPGLPPGLPPA | 21 | Q9HAH7 | |
| GPPPPGQVLPPPLAG | 251 | Q16630 | |
| PSPLAGPLQPPFPQP | 351 | Q9NQL9 | |
| LGPIPPVLPVPPGFP | 406 | P35555 | |
| PVLPVPPGFPPGPQI | 411 | P35555 | |
| PPGFPPGPQIPVPRP | 416 | P35555 | |
| PPPPPPQLPGARVLV | 106 | Q9NX05 | |
| PPRPIIGPALPPGFI | 106 | Q8IXQ4 | |
| RQGPPPPNPVAAFPP | 231 | Q6PJG2 | |
| PCPPPQAPPTLPGIF | 821 | Q9NZM4 | |
| AAIPPPPPLPGAGIP | 951 | Q9NZ56 | |
| AGIPPPPPLPGAGIP | 1006 | Q9NZ56 | |
| AGIPPPPPLPGAGIP | 1061 | Q9NZ56 | |
| LPGAGIPPPPPLPGV | 1091 | Q9NZ56 | |
| AGIPPPPPLPGAGIP | 1116 | Q9NZ56 | |
| PGAGIPPPPPLPRVG | 1136 | Q9NZ56 | |
| AGIPPPPPLPGVGIP | 1171 | Q9NZ56 | |
| QPPAFTPPLGIPPPG | 696 | O95104 | |
| PVPVPEPGLAPQGPP | 386 | Q52WX2 | |
| ELGQRVGLFPPPPPP | 706 | Q9UL51 | |
| VGLFPPPPPPPQVTS | 711 | Q9UL51 | |
| PPNFPQGLLPPFPPG | 366 | Q86TM6 | |
| VPQPPPGPAAALPPG | 11 | Q9P2Y5 | |
| AVPPPPVPVLPGAVP | 261 | Q13671 | |
| GGPVPPPIRYGPPPQ | 1776 | Q5JRA6 | |
| PPPYGAAPIGIPRPP | 51 | Q14934 | |
| GLAPPGPPQPLFPQP | 461 | O15353 | |
| PGLPQAPQGPSPRPP | 1501 | P48634 | |
| QPIPASPPPQIPPGL | 131 | O15446 | |
| PPGPLAPPQPFGPGF | 31 | P02814 | |
| PPAAPPPAGLQPLGP | 66 | Q8ND83 | |
| PPGTCPPVQPPFPLL | 836 | Q2M3G4 | |
| PGPQEPLPPTLGPPL | 186 | B8ZZ34 | |
| ILPPLPPFPPGLFPV | 741 | Q9UPS6 | |
| PPPLPLLPPCGYPGL | 261 | A6NGB9 | |
| QHPFVPGGPPPITPP | 1036 | Q9P2R6 | |
| APPVQTPLPGAPPPQ | 611 | Q15714 | |
| GGPDLPLVLPPPPPQ | 786 | Q9ULL5 | |
| PAAAVPGPPPLPGLP | 1426 | Q9ULL5 | |
| PPPGIPGQPLPSPTR | 761 | Q9C0C4 | |
| PAKVPGLEPCPPPPF | 401 | Q9NP71 | |
| GPPQLPPPAPGVHPP | 276 | Q15428 | |
| LPAIQPPPPVLPGPF | 76 | P12755 | |
| SPPLGPGLQPLAPPP | 286 | Q9Y2V3 | |
| PPNAGQPPPPLPVIA | 211 | Q70JA7 | |
| PGPIPAPIPGPAQIP | 96 | Q8N7U7 | |
| PGPISVPIPGPIPGP | 196 | Q8N7U7 | |
| VPIPGPIPGPISGPI | 201 | Q8N7U7 | |
| PIPGPISGPNPGPIP | 226 | Q8N7U7 | |
| PPLPPGPPEIVGPQN | 516 | P61129 | |
| FPVPLPPGPLEPGPG | 1971 | O15027 | |
| PPPRPWGVGLPQPLP | 296 | A6NJB7 | |
| VQPPASIGPPLGVPP | 366 | A7XYQ1 | |
| IPPSPPPPYGPGRIQ | 76 | Q99954 | |
| LLQPPGPELPPVPFP | 151 | O14512 | |
| PGIPPPGVPQGIPPQ | 631 | P49750 | |
| PAGPPPPPAPALVGL | 11 | O96008 | |
| ALVGLPPPPPSPPGF | 21 | O96008 | |
| GPAPFPLPALPLPPG | 176 | A6NIX2 | |
| PAVPPPPAPLQIAPG | 366 | Q92558 | |
| GPPPGPPPPQVVQMY | 201 | Q9Y2W2 | |
| LVPPLGPAPPGLFPP | 511 | Q9Y2W2 | |
| GPAPPGLFPPAPLPN | 516 | Q9Y2W2 | |
| QGPPPTVPPPPRVVD | 51 | Q9NSU2 | |
| VPAPGPGPIPAPIPG | 161 | P0DV77 | |
| PGPIPAPIPGPAQIP | 166 | P0DV77 |